newsfilter
← Latest News
GlobeNewswire·

Vor Bio to Participate in Upcoming Investor Conferences

BOSTON, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Vor Bio (NASDAQ:VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that it will participate in the following